Literature DB >> 18312293

A molecular basis for agonist and antagonist actions at GABA(C) receptors.

Heba Abdel-Halim1, Jane R Hanrahan, David E Hibbs, Graham A R Johnston, Mary Chebib.   

Abstract

We modelled the N-terminal ligand-binding domain of the rho1 GABA(C) receptor based on the Lymnaea stagnalis acetylcholine-binding protein (L-AChBP) crystal structure using comparative modelling and validated using flexible docking guided by known mutagenesis studies. A range of known rho1 GABA(C) receptor ligands comprising seven full agonists, 10 partial agonists, 43 antagonists and 12 inactive molecules were used to evaluate and validate the models. Of the 50 models identified, six models that allowed flexible ligand docking in accordance with the experimental data were selected and used to study detailed receptor-ligand interactions. The most refined model to accommodate all known active ligands featured a cavity comprising of a volume of 488 A(3). A detailed analysis of the interaction between the rho1 GABA(C) receptor model and the docked ligands revealed possible H-bonds and cation-pi interactions between the different ligands and binding site residues. Based on quantum mechanical/molecular mechanical (QM/MM) calculations, the model showed distinctive conformations of loop C that provided a molecular basis for agonist and antagonist actions. Agonists elicit loop C closure, while a more open loop C was observed upon antagonist binding. The model differentiates the role for key residues known to be involved in either binding and/or gating.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18312293     DOI: 10.1111/j.1747-0285.2008.00642.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  18 in total

1.  Structural rearrangements in loop F of the GABA receptor signal ligand binding, not channel activation.

Authors:  Alpa Khatri; Anna Sedelnikova; David S Weiss
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

2.  2-Aminoethyl methylphosphonate, a potent and rapidly acting antagonist of GABA(A)-ρ1 receptors.

Authors:  An Xie; Jun Yan; Lan Yue; Feng Feng; Fozia Mir; Heba Abdel-Halim; Mary Chebib; Guy C Le Breton; Robert F Standaert; Haohua Qian; David R Pepperberg
Journal:  Mol Pharmacol       Date:  2011-08-02       Impact factor: 4.436

Review 3.  GABA-ρ receptors: distinctive functions and molecular pharmacology.

Authors:  Moawiah M Naffaa; Sandy Hung; Mary Chebib; Graham A R Johnston; Jane R Hanrahan
Journal:  Br J Pharmacol       Date:  2017-04-12       Impact factor: 8.739

Review 4.  Computational methods of studying the binding of toxins from venomous animals to biological ion channels: theory and applications.

Authors:  Dan Gordon; Rong Chen; Shin-Ho Chung
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

5.  Novel Cyclic Phosphinic Acids as GABAC ρ Receptor Antagonists: Design, Synthesis, and Pharmacology.

Authors:  Navnath Gavande; Izumi Yamamoto; Noeris K Salam; Tu-Hoa Ai; Peter M Burden; Graham A R Johnston; Jane R Hanrahan; Mary Chebib
Journal:  ACS Med Chem Lett       Date:  2010-10-19       Impact factor: 4.345

6.  Design, Synthesis, and Pharmacological Evaluation of Fluorescent and Biotinylated Antagonists of ρ1 GABAC Receptors.

Authors:  Navnath Gavande; Hye-Lim Kim; Munikumar R Doddareddy; Graham A R Johnston; Mary Chebib; Jane R Hanrahan
Journal:  ACS Med Chem Lett       Date:  2013-02-18       Impact factor: 4.345

7.  A hydrophobic area of the GABA ρ₁ receptor containing phenylalanine 124 influences both receptor activation and deactivation.

Authors:  J E Carland; I Yamamoto; J R Hanrahan; H Abdel-Halim; T M Lewis; N Absalom; M Chebib
Journal:  J Mol Neurosci       Date:  2014-05-10       Impact factor: 3.444

8.  Novel, potent, and selective GABAC antagonists inhibit myopia development and facilitate learning and memory.

Authors:  Mary Chebib; Tina Hinton; Katrina L Schmid; Darren Brinkworth; Haohua Qian; Susana Matos; Hye-Lim Kim; Heba Abdel-Halim; Rohan J Kumar; Graham A R Johnston; Jane R Hanrahan
Journal:  J Pharmacol Exp Ther       Date:  2008-11-04       Impact factor: 4.030

9.  Structural model of rho1 GABAC receptor based on evolutionary analysis: Testing of predicted protein-protein interactions involved in receptor assembly and function.

Authors:  Larisa Adamian; Hélène A Gussin; Yan Yuan Tseng; Niraj J Muni; Feng Feng; Haohua Qian; David R Pepperberg; Jie Liang
Journal:  Protein Sci       Date:  2009-11       Impact factor: 6.725

10.  Guanidino acids act as rho1 GABA(C) receptor antagonists.

Authors:  Mary Chebib; Navnath Gavande; Kit Yee Wong; Anna Park; Isabella Premoli; Kenneth N Mewett; Robin D Allan; Rujee K Duke; Graham A R Johnston; Jane R Hanrahan
Journal:  Neurochem Res       Date:  2009-04-23       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.